Allison Portnoy
@aportnoy.bsky.social
Asst Prof @BUSPH Global Health | affiliate @decisionscience @HarvardChanSPH | @vaccineimpact and economic modeling | health equity | SFF nerd | she/her
CHDS’ Allison Portnoy (@aportnoy.bsky.social), Nick Menzies, and collaborators examined how the dismantling of the USAID and potential reductions in support from the Global Fund could affect the household economic burden of tuberculosis in low- and middle-income countries. shorturl.at/7f4Qa
Who builds disease models matters. Researchers say local experts must lead to ensure global health decisions are fair and effective. AI adds speed—but also risk without context. Learn more: www.worldpop.org/blog/rebalan... #GlobalHealth #AI #HealthEquity 🌍📊 @sotongeogenviron.bsky.social
Rebalancing Global Health: Why Local Leadership Matters in Disease Modelling
Experts call for country-led infectious disease modelling to improve equity, warning that AI and current practices risk widening global health gaps.
worldpop.org
University of Oslo and CHDS researchers, including CHDS’s @emilyannika.bsky.social, Jane Kim, Stephen Sy & @aportnoy.bsky.social, find that HPV vaccine may reduce the number of cervical cancer screenings women will need over their lifetime. tinyurl.com/22zkart4
HPV Vaccine May Reduce Cervical Cancer Screenings – Center for Health Decision Science
tinyurl.com
With Nick Menzies and @lshtm-tbmod.bsky.social, our new modeling study estimated how reductions in donor funding could affect the economic burden of #TB on patients, especially among the poorest households journals.plos.org/plosmedicine...
The potential impact of reduced international donor funding on the household economic burden of tuberculosis in low- and middle-income countries: A modeling study
In a modelling study, Allison Portnoy and colleagues investigate the potential impact of reduced international donor funding on the household economic burden of Tuberculosis in low- and middle-income ...
journals.plos.org
Thanks to @buhaririinstitute.bsky.social for this profile on my K01 -- I hope the work lives up to it! www.bu.edu/hic/2026/02/...
From Research to Policy Impact: BU’s Allison Portnoy Models RSV Prevention From Newborns to the Elderly | Rafik Hariri Institute for Computing and Computational Science & Engineering
bu.edu
🚨JOB OPPORTUNITY! Apply to come work with me on vaccine impact modeling (specifically #HPV and #RSV) @busph.bsky.social! jobs.silkroad.com/BU/External/...
Post-doctoral Research Fellow in Vaccine Impact Modeling, Global Health, School of Public Health - Boston, MA, United States - Boston University
Find a career with Boston University
jobs.silkroad.com
To all the teachers and professors I've ever had -- thank you. You made it look easy, but oh jeez is it a lot
Finally received the notice of award for my K01 to estimate the population health and economic impact of #RSV prevention @busph.bsky.social!
Please join us next week for the February #LSHTMVaccineCentre seminar! Featuring talks by Dr Allison Portnoy (@aportnoy.bsky.social) & Dr Kayoko Shioda from @busph.bsky.social on reaching #zero-dose children and target trial emulation 📆 Thurs 27 Feb 🕗 14–15:00 GMT 📍 Online tinyurl.com/23x2z4an
Vaccine Centre webinar February | LSHTM
This webinar will features two speakers from Boston University School of Public Health, Dr Allison Portnoy and Dr Kayoko Shioda, speaking on their current vaccine research. Dr Allison Portnoy will be
tinyurl.com
New at Vaccine from our team (led by Ali Moghtaderi). Declining school vax rates; especially in states that allow for non-med exemptions. States that *removed* exemptions experienced an increase. With: @thcallaghan.bsky.social @aportnoy.bsky.social www.sciencedirect.com/science/arti...
Evidence on trends in uptake of childhood vaccines and association with COVID-19 vaccination rates
Childhood vaccination rates have declined in recent years; there is also concern that resistance to COVID-19 vaccines could spill over to childhood va…
sciencedirect.com